These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1687 related items for PubMed ID: 26337620

  • 1. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS, Shehata I, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [Abstract] [Full Text] [Related]

  • 2. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Basavarajaiah S, Naganuma T, Latib A, Sticchi A, Ciconte G, Panoulas V, Chieffo A, Montorfano M, Carlino M, Colombo A.
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
    Nguyen VPT, Kim C, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
    [Abstract] [Full Text] [Related]

  • 4. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2018 Aug 01; 92(2):285-299. PubMed ID: 29024274
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
    Oh PC, Suh SY, Kang WC, Lee K, Han SH, Ahn T, Shin EK.
    Korean J Intern Med; 2016 May 01; 31(3):501-6. PubMed ID: 26951915
    [Abstract] [Full Text] [Related]

  • 6. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H, Ruparelia N, Latib A, Miyazaki T, Sato K, Mangieri A, Contri R, Stella S, Figini F, Chieffo A, Carlino M, Montorfano M, Colombo A.
    JACC Cardiovasc Interv; 2015 Oct 01; 8(12):1586-94. PubMed ID: 26386758
    [Abstract] [Full Text] [Related]

  • 7. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H, Joo HJ, Park JH, Hong SJ, Yu CW, Lim DS.
    BMC Cardiovasc Disord; 2020 Feb 18; 20(1):83. PubMed ID: 32070287
    [Abstract] [Full Text] [Related]

  • 8. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S, Joner M, Schneider S, Tölg R, Zrenner B, Repp J, Starkmann A, Xhepa E, Ibrahim T, Cassese S, Fusaro M, Ott I, Hengstenberg C, Schunkert H, Abdel-Wahab M, Laugwitz KL, Kastrati A, Byrne RA, ISAR-DESIRE 4 Investigators.
    JACC Cardiovasc Interv; 2017 Jul 10; 10(13):1332-1340. PubMed ID: 28683939
    [Abstract] [Full Text] [Related]

  • 9. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X, Lu W, Wang X, Pan L, Fu W, Liu Q, Han Z, Sun G, Qin X, Li R, Zheng X, Shan Y, Qiu C.
    Int J Cardiovasc Imaging; 2020 Feb 10; 36(2):171-178. PubMed ID: 31919705
    [Abstract] [Full Text] [Related]

  • 10. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B, Qian J, Ge J, Wang J, Chen F, Chen J, Wei M, Chen Y, Yang Y, Gao R, PEPCAD China ISR investigators.
    Catheter Cardiovasc Interv; 2016 Mar 10; 87 Suppl 1():624-9. PubMed ID: 26775079
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
    Koch T, Cassese S, Xhepa E, Mayer K, Tölg R, Hoppmann P, Laugwitz KL, Byrne RA, Kastrati A, Kufner S.
    Catheter Cardiovasc Interv; 2020 Nov 10; 96(5):1008-1015. PubMed ID: 31789486
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H, Waliszewski M, Brachmann J, Hohenforst-Schmidt W, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Schlundt C, Zimmermann S, Lonke S, von Cranach M, Markovic S, Daniel WG, Achenbach S, Wöhrle J.
    JACC Cardiovasc Interv; 2015 Nov 10; 8(13):1695-700. PubMed ID: 26476609
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis.
    Wańha W, Iwańczyk S, Januszek R, Wolny R, Tomasiewicz B, Kuliczkowski W, Reczuch K, Pawlus P, Pawłowski TZ, Kuźma Ł, Kubler P, Niezgoda P, Kubica J, Gil RJ, Pawłowski TF, Gąsior M, Jaguszewski M, Wybraniec M, Witkowski A, Kowalewski M, D'Ascenzo F, Greco A, Bartuś S, Lesiak M, Grygier M, Wojakowski W, Cortese B.
    Circ Cardiovasc Interv; 2024 Sep 10; 17(9):e014064. PubMed ID: 39051094
    [Abstract] [Full Text] [Related]

  • 14. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S, Cassese S, Valeskini M, Neumann FJ, Schulz-Schüpke S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA, ISAR-DESIRE 3 Investigators.
    JACC Cardiovasc Interv; 2015 Jun 10; 8(7):877-84. PubMed ID: 26003022
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M, Schröder J, Pross V, Marx N, Hoffmann R.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):881-7. PubMed ID: 23765557
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y, Chen J, Bi Y, Xie S, Liao T, Zhang Y, Kislauskis E, Wu T, Laham R, Xiao J.
    Catheter Cardiovasc Interv; 2020 Aug 01; 96(2):E129-E141. PubMed ID: 31714010
    [Abstract] [Full Text] [Related]

  • 17. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM, Garcia Camarero T, Lozano Ruiz-Poveda F, Urbano-Carrillo CA, Sánchez Pérez I, Cano-García M, Saez R, Andrés Morist A, Molina E, Pinar E, Torres A, Lezcano EJ, Gutierrez H, Arnold RJ, Zueco J.
    Cardiovasc Revasc Med; 2020 Apr 01; 21(4):508-513. PubMed ID: 31401071
    [Abstract] [Full Text] [Related]

  • 18. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H, Wöhrle J, Brachmann J, Hohenforst-Schmidt W, Schlundt C, Lonke S, von Cranach M, Markovic S, Achenbach S, Waliszewski M.
    Catheter Cardiovasc Interv; 2016 Oct 01; 88(4):529-534. PubMed ID: 26893095
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B.
    EuroIntervention; 2015 Dec 01; 11(8):926-34. PubMed ID: 25169589
    [Abstract] [Full Text] [Related]

  • 20. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
    Alfonso F, Pérez-Vizcayno MJ, Cuesta J, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Cequier A, Velázquez M, Moreno R, Mainar V, Domínguez A, Moris C, Molina E, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández-Pérez C, RIBS IV Study Investigators (Under the Auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology).
    JACC Cardiovasc Interv; 2018 May 28; 11(10):981-991. PubMed ID: 29798776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.